{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:13:58Z","timestamp":1751951638601,"version":"3.37.3"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Allergy Immunology Fellowship Program"},{"name":"Scripps Research Institute (Green Hospital); and the United States Department of Defense Office of Naval Research (Graduate Education Program)"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Live attenuated zoster vaccine (Zostavax) was used to test the hypothesis that constitutive level of interleukin 10 (IL-10), which may be high in elderly subjects, impairs vaccine efficacy. If constitutive IL-10 impairs vaccine efficacy, the effectiveness of viral vaccines might be improved by transient inhibition of IL-10 before vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Zostavax was given to 26 patients (age, 60\u201380 years). IL-10 and immunity to varicella zoster virus (VZV) were measured at baseline and after vaccination. Fluorescent antibody to membrane antigen (FAMA) assays and glycoprotein enzyme-linked immunosorbent assays (gpELISAs) were used to assess humoral immunity; anti\u2013varicella virus T-cell responses were studied in a subset of subjects. In a prospective animal model, T-cell responses to chimeric vaccines against lymphocytic choriomeningitis virus (LCMV) were assessed in mice that express or lack IL-10.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>FAMA assays revealed significant boosting (by 4-fold) of humoral immunity, which occurred only in subjects (10 of 26) with a low constitutive IL-10 level (ie, &lt;20 pg\/mL); moreover, the Zostavax-induced FAMA and gpELISA responses were inversely related to the constitutive IL-10 level. Significant VZV-specific T-cell responses followed vaccination only in subjects with a low constitutive IL-10 level. Vaccine-induced LCMV-specific T-cell responses in mice lacking IL-10 were greater than in wild-type animals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A high constitutive IL-10 level adversely affects vaccine efficacy.<\/jats:p><\/jats:sec>","DOI":"10.1093\/infdis\/jiy660","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T04:22:00Z","timestamp":1542082920000},"page":"1338-1346","source":"Crossref","is-referenced-by-count":8,"title":["High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine"],"prefix":"10.1093","volume":"219","author":[{"given":"Anne A","family":"Gershon","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brooks","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Center, University of Toronto Medical School, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald D","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Viral-Immunobiology Laboratory, Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K","family":"Chin","sequence":"additional","affiliation":[{"name":"Allergy, Asthma, Clinical Immunology Clinic, Naval Medical Center Portsmouth, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B A","family":"Oldstone","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Scripps Clinic Medical Group, La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D","family":"Gershon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"2019070109523910500_CIT0001","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"2019070109523910500_CIT0002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0003","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"V\u00e1zquez","year":"2001","journal-title":"N Engl J Med"},{"key":"2019070109523910500_CIT0004","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"2019070109523910500_CIT0005","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/infdis\/jit342","article-title":"Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine","volume":"208","author":"Levin","year":"2013","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0006","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1189\/jlb.0306190","article-title":"High interleukin-10 production is associated with low antibody response to influenza vaccination in the elderly","volume":"80","author":"Corsini","year":"2006","journal-title":"J Leukoc Biol"},{"key":"2019070109523910500_CIT0007","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s10620-014-3358-1","article-title":"Role of IL-10-producing regulatory B cells in chronic hepatitis B virus infection","volume":"60","author":"Gong","year":"2015","journal-title":"Dig Dis Sci"},{"key":"2019070109523910500_CIT0008","first-page":"341","article-title":"VZV T cell-mediated immunity","volume-title":"Curr top microbiol immunol","author":"Weinberg","year":"2010","edition":"2010\/05\/18 ed"},{"key":"2019070109523910500_CIT0009","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.06623-11","article-title":"Immune correlates of herpes zoster in HIV-infected children and youth","volume":"86","author":"Weinberg","year":"2012","journal-title":"J Virol"},{"key":"2019070109523910500_CIT0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/529043","article-title":"Primary vaccine failure after 1 dose of varicella vaccine in healthy children","volume":"197","author":"Michalik","year":"2008","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0011","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiu279","article-title":"Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve","volume":"210","author":"Gilbert","year":"2014","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197401312900503","article-title":"Zoster immune globulin. A further assessment","volume":"290","author":"Gershon","year":"1974","journal-title":"N Engl J Med"},{"key":"2019070109523910500_CIT0013","doi-asserted-by":"crossref","first-page":"20577","DOI":"10.1038\/srep20577","article-title":"Serological evaluation of immunity to the varicella-zoster virus based on a novel competitive enzyme-linked immunosorbent assay","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2019070109523910500_CIT0014","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/130.6.669","article-title":"Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence","volume":"130","author":"Williams","year":"1974","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.20071948","article-title":"IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection","volume":"205","author":"Brooks","year":"2008","journal-title":"J Exp Med"},{"key":"2019070109523910500_CIT0016","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"key":"2019070109523910500_CIT0017","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.chom.2012.04.016","article-title":"Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection","volume":"11","author":"Walsh","year":"2012","journal-title":"Cell Host Microbe"},{"key":"2019070109523910500_CIT0018","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1073\/pnas.0811139106","article-title":"IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection","volume":"105","author":"Brooks","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019070109523910500_CIT0019","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1128\/JVI.00486-11","article-title":"Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest","volume":"85","author":"Popkin","year":"2011","journal-title":"J Virol"},{"key":"2019070109523910500_CIT0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1008301602785","article-title":"Interleukin-10 levels are often elevated in serum of adults with Hodgkin\u2019s disease and are associated with inferior failure-free survival","volume":"10","author":"Sarris","year":"1999","journal-title":"Ann Oncol"},{"key":"2019070109523910500_CIT0021","doi-asserted-by":"crossref","first-page":"434010","DOI":"10.1155\/2013\/434010","article-title":"Cytokine levels in the serum of healthy subjects","volume":"2013","author":"Kleiner","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2019070109523910500_CIT0022","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"n Engl J Med"},{"key":"2019070109523910500_CIT0023","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1016\/j.vaccine.2018.06.004","article-title":"A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults","volume":"36","author":"Baay","year":"2018","journal-title":"Vaccine"},{"key":"2019070109523910500_CIT0024","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/infdis\/jix484","article-title":"Clinical usage of the adjuvanted herpes zoster subunit vaccine (HZ\/su): revaccination of recipients of live attenuated zoster vaccine and coadministration with a seasonal influenza vaccine","volume":"216","author":"Oxman","year":"2017","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0025","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.1300293","article-title":"Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10","volume":"191","author":"Garner-Spitzer","year":"2013","journal-title":"J Immunol"},{"key":"2019070109523910500_CIT0026","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/infdis\/jiu541","article-title":"Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells","volume":"211","author":"Niesen","year":"2015","journal-title":"J Infect Dis"},{"key":"2019070109523910500_CIT0027","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1051\/ject\/2004362197","article-title":"Relationship of aging and cardiac IL-10","volume":"36","author":"Dotson","year":"2004","journal-title":"J Extra Corpor Technol"},{"key":"2019070109523910500_CIT0028","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/cimm.1994.1076","article-title":"Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice","volume":"154","author":"Hobbs","year":"1994","journal-title":"Cell Immunol"},{"key":"2019070109523910500_CIT0029","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"2019070109523910500_CIT0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"K\u00fchn","year":"1993","journal-title":"Cell"},{"key":"2019070109523910500_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"2019070109523910500_CIT0032","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/00365540110077218","article-title":"Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster","volume":"34","author":"Haanp\u00e4\u00e4","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"2019070109523910500_CIT0033","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"2019070109523910500_CIT0034","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"2019070109523910500_CIT0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/17402520600579028","article-title":"Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies","volume":"13","author":"Ejrnaes","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"2019070109523910500_CIT0036","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0198-8859(03)00080-6","article-title":"IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection","volume":"64","author":"Lio","year":"2003","journal-title":"Hum Immunol"},{"key":"2019070109523910500_CIT0037","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiu279","article-title":"Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve","volume":"210","author":"Gilbert","year":"2014","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/8\/1338\/28890734\/jiy660.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T01:00:59Z","timestamp":1694048459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/8\/1338\/5184646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,11,16]]},"published-print":{"date-parts":[[2019,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy660","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2019,4,15]]},"published":{"date-parts":[[2018,11,16]]}}}